Sagittarius Life Science (ROCO:3205) Net Margin %: -28.73% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3205 Sagittarius Life Science Corp ROCO:3205
47 GF Score
Price NT$50.20
GF Value NT$17.93
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sagittarius Life Science Net Margin %?

Sagittarius Life Science ROCO:3205 -1.38% 47 Net Margin % is -28.73% as of Dec. 2025. GuruFocus rates ROCO:3205 with a GF Score™ of 47/100 and a GF Value™ of NT$17.93 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 941 Biotechnology companies, Sagittarius Life Science ranks better than 64.29% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Sagittarius Life Science's Net Income for the three months ended in Dec. 2025 was NT$-11.4 Mil. Sagittarius Life Science's Revenue for the three months ended in Dec. 2025 was NT$39.6 Mil. Therefore, Sagittarius Life Science's net margin for the quarter that ended in Dec. 2025 was -28.73%.

The historical rank and industry rank for Sagittarius Life Science's Net Margin % or its related term are showing as below:

ROCO:3205' s Net Margin % Range Over the Past 10 Years
Min: -27.24   Med: -14.17   Max: 19.37
Current: -14.32

ROCO:3205's Net Margin % is ranked better than
64.29% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:3205: -14.32

Sagittarius Life Science  (ROCO:3205) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sagittarius Life Science Net Margin % Related Terms

Sagittarius Life Science Net Margin % Historical Data

* Premium members only.

The historical data trend for Sagittarius Life Science's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagittarius Life Science Net Margin % Chart

Sagittarius Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.71 -14.02 -12.50 -10.38 -14.32

Sagittarius Life Science Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.90 -15.54 -13.97 -7.29 -28.73

ROCO:3205 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Sagittarius Life Science's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sagittarius Life Science Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's Net Margin % falls into.


ROCO:3205
47GF Score
Sagittarius Life Science Corp ROCO:3205
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sagittarius Life Science Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sagittarius Life Science's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-49.564/346.08
=-14.32 %

Sagittarius Life Science's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-11.366/39.567
=-28.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -28.73% mean?
Sagittarius Life Science (ROCO:3205) has a Net Margin % of -28.73% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Sagittarius Life Science and its competitors. According to the industry distribution chart, Sagittarius Life Science ranks #336 out of 941 companies in the Biotechnology industry, placing it in the top 35.7%.
Is Sagittarius Life Science's Net Margin % too high?
Sagittarius Life Science's current Net Margin % is -28.73%. Based on the distribution chart, Sagittarius Life Science ranks #336 out of 941 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sagittarius Life Science has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sagittarius Life Science's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sagittarius Life Science ranks #336 out of 941 companies for Net Margin %. This puts Sagittarius Life Science in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sagittarius Life Science and its competitors. Sagittarius Life Science's current Net Margin % is -28.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagittarius Life Science stock overvalued right now?
Based on GuruFocus' analysis, Sagittarius Life Science (ROCO:3205) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$17.93, compared to a current price of NT$50.20 — trading 180% above its estimated fair value. The current Net Margin % is -28.73%. Sagittarius Life Science's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sagittarius Life Science (ROCO:3205), the current Net Margin % is -28.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sagittarius Life Science (ROCO:3205) Overvalued in 2026?

Based on GuruFocus' analysis, Sagittarius Life Science stock appears to be overvalued. The current stock price of NT$50.20 is trading 180% above its estimated GF Value™ of NT$17.93. GuruFocus considers Sagittarius Life Science to be Significantly Overvalued.

Key valuation signals for ROCO:3205:

  • Net Margin %: -28.73%
  • GF Value™: NT$17.93 vs. price of NT$50.20 (180% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the ROCO:3205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sagittarius Life Science Business Description

Address No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Sagittarius Life Science Corp is a Taiwan-based company engaged in the biotechnology and pharmaceutical sectors. The segment includes: Food and Others, with the majority of revenue from Food.
47GF Score

Get the complete analysis for ROCO:3205

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.20
Price
NT$17.93
GF Value